Long-Term Efficacy and Safety of Tretinoin Emollient Cream 0.05% in the Treatment of Photodamaged Facial SkinA Two-Year, Randomized, Placebo-Controlled Trial

被引：0

作者：

Sewon Kang

Wilma Bergfeld

Alice B. Gottlieb

Janet Hickman

John Humeniuk

Steven Kempers

Mark Lebwohl

Nicholas Lowe

Amy McMichael

James Milbauer

Tania Phillips

Jerold Powers

David Rodriguez

Ronald Savin

Joel Shavin

Daniel Sherer

Nancy Silvis

Richard Weinstein

Jonathan Weiss

Craig Hammerberg

Gary J Fisher

Marge Nighland

Rachel Grossman

Judit Nyirady

机构：

[1] University of Michigan,Department of Dermatology

[2] The Cleveland Clinic Foundation,Department of Dermatology

[3] UMDNJ-Robert Wood Johnson Medical School,School of Medicine, Department of Dermatology

[4] The Education & Research Foundation,Department of Dermatology

[5] Inc.,Dermatology Clinic

[6] Hill Top-MedQuest Centers for Research,undefined

[7] Minnesota Clinical Study Center,undefined

[8] Mount Sinai Medical Center,undefined

[9] Clinical Research Specialists,undefined

[10] Wake Forest University,undefined

[11] Research Testing Laboratory,undefined

[12] Boston University School of Medicine,undefined

[13] Hill Top Research,undefined

[14] Inc.,undefined

[15] International Dermatology Research,undefined

[16] Inc.,undefined

[17] Savin Dermatology Center,undefined

[18] Gwinnett Clinical Research Center,undefined

[19] Inc.,undefined

[20] University of Arizona,undefined

[21] Diablo Research,undefined

[22] Johnson & Johnson Consumer and Personal Products Worldwide,undefined

[23] Novartis Pharmaceuticals Corporation,undefined

来源：

American Journal of Clinical Dermatology | 2005年 / 6卷

关键词：

Tretinoin; Topical Tretinoin; Photodamaged Skin; Emollient Cream; Fine Wrinkle;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Background: Long-term (>1 year) placebo-controlled studies of tretinoin in the treatment of photodamaged skin have not been conducted. Recently, we conducted a 2-year placebo-controlled study of tretinoin emollient cream 0.05%, including histopathologic assessment of safety and analysis of markers of collagen deposition.

引用

页码：245 / 253

页数：8

共 50 条

[31] Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience
Sorensen, OH
Crawford, GM
Mulder, H
Hosking, DJ
Gennari, C
Mellstrom, D
Pack, S
Wenderoth, D
Cooper, C
Reginster, JY
BONE, 2003, 32 (02) : 120 - 126
[32] Long-Term Effects of Chondroitins 4 and 6 Sulfate on Knee Osteoarthritis The Study on Osteoarthritis Progression Prevention, a Two-Year, Randomized, Double-Blind, Placebo-Controlled Trial
Kahan, Andre
Uebelhart, Daniel
De Vathaire, Florent
Delmas, Pierre D.
Reginster, Jean-Yves
ARTHRITIS AND RHEUMATISM, 2009, 60 (02): : 524 - 533
[33] Efficacy and safety of 4-aminopyridine in patients with long-term spinal cord injury:: A randomized, double-blind, placebo-controlled trial
Grijalva, I
Guízar-Sahagún, G
Castañeda-Hernández, G
Mino, D
Maldonado-Julián, H
Vidal-Cantú, G
Ibarra, A
Serra, O
Salgado-Ceballos, H
Arenas-Hernández, R
PHARMACOTHERAPY, 2003, 23 (07): : 823 - 834
[34] LONG-TERM SAFETY AND EFFICACY OF GOLIMUMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS: RESULTS THROUGH 5 YEARS OF A RANDOMIZED, PLACEBO- CONTROLLED TRIAL
Deodhar, Atul
Braun, Jurgen
Inman, Robert
van der Heijde, Desiree
Zhou, Yiying
Hsu, Ben
RHEUMATOLOGY, 2014, 53 : 142 - 142
[35] Safety of topical sildenafil cream, 3.6% in a randomized, placebo-controlled trial for the treatment of female sexual arousal disorder
Thurman, Andrea R.
Johnson, Isabella
Cornell, Katherine A.
Hatheway, Jessica
Kim, Noel N.
Parish, Sharon J.
Dart, Clint
Friend, David R.
Goldstein, Andrew
JOURNAL OF SEXUAL MEDICINE, 2024, 21 (09): : 793 - 799
[36] Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial
Kimball, Alexa B.
Prens, Errol P.
Passeron, Thierry
Maverakis, Emanual
Turchin, Irina
Beeck, Stefan
Drogaris, Leonidas
Geng, Ziqian
Zhan, Tianyu
Messina, Izabella
Bechara, Falk G.
DERMATOLOGY AND THERAPY, 2023, 13 (05) : 1099 - 1111
[37] Efficacy and safety of propranolol for treatment of temporomandibular disorder pain: a randomized, placebo-controlled clinical trial
Tchivileva, Inna E.
Hadgraft, Holly
Lim, Pei Feng
Di Giosia, Massimiliano
Ribeiro-Dasilva, Margarete
Campbell, John H.
Willis, Janet
James, Robert
Herman-Giddens, Marcus
Fillingim, Roger B.
Ohrbach, Richard
Arbes, Samuel J.
Slade, Gary D.
PAIN, 2020, 161 (08) : 1755 - 1767
[38] Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial
Alexa B. Kimball
Errol P. Prens
Thierry Passeron
Emanual Maverakis
Irina Turchin
Stefan Beeck
Leonidas Drogaris
Ziqian Geng
Tianyu Zhan
Izabella Messina
Falk G. Bechara
Dermatology and Therapy, 2023, 13 : 1099 - 1111
[39] A PLACEBO-CONTROLLED STUDY OF EFFICACY AND SAFETY OF ARIPIPRAZOLE ONCE-MONTHLY FOR LONG-TERM MAINTENANCE TREATMENT IN SCHIZOPHRENIA
Eramo, A.
Fleischhacker, W. W.
Sanchez, R.
Perry, P.
Jin, N.
Johnson, B.
McQuade, R. D.
Carson, W. H.
Kane, J.
EUROPEAN PSYCHIATRY, 2013, 28
[40] A randomized long-term placebo-controlled multicenter trial of pergolide in the treatment of RLS with central evaluation of polysomnographic data
Trenkwalder, CM
Brandenburg, U
Hundemer, HP
Lledo, A
Quail, D
Swieca, J
Polo, O
Wetter, TC
Strambi
deGroen, H
SLEEP, 2001, 24 : A18 - A18

← 1 2 3 4 5 →